PI
VRTX icon

PEAK6 Investments’s Vertex Pharmaceuticals VRTX Stock Holding History

PEAK6 Investments’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$3.72M Buy
8,000
+100
+1% +$48K 0.01% 1119
2024
Q2 		$3.7M Buy
+7,900
New +$3.43M 0.01% 1006
2024
Q1 		– Sell
-4,700
Closed -$1.91M – 4804
2023
Q4 		$1.91M Buy
4,700
+2,800
+147% +$1.03M 0.01% 1559
2023
Q3 		$661K Sell
1,900
-300
-14% -$105K ﹤0.01% 2157
2023
Q2 		$774K Sell
2,200
-22,400
-91% -$7.55M ﹤0.01% 1887
2023
Q1 		$7.75M Buy
24,600
+16,200
+193% +$4.86M 0.04% 497
2022
Q4 		$2.43M Sell
8,400
-5,400
-39% -$1.65M 0.01% 1186
2022
Q3 		$4M Sell
13,800
-47,900
-78% -$13.8M 0.02% 979
2022
Q2 		$17.5M Buy
61,700
+61,400
+20,467% +$16.4M 0.03% 524
2022
Q1 		$78K Buy
+300
New +$71.2K ﹤0.01% 4407
2021
Q4 		– Sell
-14,800
Closed -$2.69M – 5853
2021
Q3 		$2.69M Sell
14,800
-198,400
-93% -$38.7M 0.01% 1677
2021
Q2 		$43M Buy
213,200
+170,300
+397% +$35.6M 0.1% 176
2021
Q1 		$9.22M Buy
42,900
+9,500
+28% +$2.09M 0.02% 680
2020
Q4 		$7.89M Buy
33,400
+6,700
+25% +$1.54M 0.02% 797
2020
Q3 		$7.27M Sell
26,700
-17,800
-40% -$4.91M 0.02% 754
2020
Q2 		$12.9M Sell
44,500
-32,000
-42% -$8.68M 0.04% 389
2020
Q1 		$18.2M Buy
76,500
+60,800
+387% +$13.9M 0.11% 177
2019
Q4 		$3.44M Sell
15,700
-47,700
-75% -$9.65M 0.02% 792
2019
Q3 		$10.7M Sell
63,400
-31,900
-33% -$5.64M 0.07% 331
2019
Q2 		$17.5M Buy
95,300
+28,000
+42% +$4.89M 0.12% 185
2019
Q1 		$12.4M Sell
67,300
-36,900
-35% -$6.82M 0.07% 296
2018
Q4 		$17.3M Buy
104,200
+13,700
+15% +$2.37M 0.11% 177
2018
Q3 		$17.4M Buy
+90,500
New +$16.1M 0.08% 257

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

PEAK6 Investments's VRTX Position: Q3 2024 in Review

PEAK6 Investments increased its Vertex Pharmaceuticals (VRTX) stake by 8,200% in Q3 2024, buying an estimated $39.4K and bringing the position to 83 shares worth $38.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3144.

PEAK6 Investments first reported a position in VRTX in Q1 2019 and has held it in 19 quarters since. The position peaked at $12.4M in Q4 2020. 1,545 funds tracked by Wall St. Rank hold VRTX as of Q3 2024.

  • PEAK6 Investments held 83 shares of Vertex Pharmaceuticals worth $38.7K as of Q3 2024.
  • PEAK6 Investments bought 82 Vertex Pharmaceuticals shares in Q3 2024, an estimated $39.4K.
  • Vertex Pharmaceuticals made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #3144 holding.
  • PEAK6 Investments first reported a position in Vertex Pharmaceuticals in Q1 2019 and has held it in 19 quarters since.
  • PEAK6 Investments's Vertex Pharmaceuticals position peaked at $12.4M in Q4 2020.
  • 1,545 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.